Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study
Wei, Jingwei3,15; Jiang, Hanyu14; Zeng, Mengsu12,13; Wang, Meiyun2,11; Niu, Meng10; Gu, Dongsheng3,15; Chong, Huanhuan12,13; Zhang, Yanyan9; Fu, Fangfang2,11; Zhou, Mu1
刊名CANCERS
2021-05-01
卷号13期号:10页码:19
关键词hepatocellular carcinoma microvascular invasion magnetic resonance imaging computed tomography deep learning
DOI10.3390/cancers13102368
英文摘要

Simple Summary Microvascular invasion (MVI) is an independent risk factor for postoperative recurrence of hepatocellular carcinoma (HCC). Preoperative knowledge of MVI would assist with tailored surgical strategy making to prolong patient survival. Previous radiological studies proved the role of noninvasive medical imaging in MVI prediction. However, hitherto, deep learning methods remained unexplored for this clinical task. As an end-to-end self-learning strategy, deep learning may not only achieve improved prediction accuracy, but may also visualize high-risk areas of invasion by generating attention maps. In this multicenter study, we developed deep learning models to perform MVI preoperative assessments using two imaging modalities-computed tomography (CT) and gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI). A head-to-head prospective validation was conducted to verify the validity of deep learning models and achieve a comparison between CT and EOB-MRI for MVI assessment. The findings put forward a better understanding of MVI preoperative prediction in HCC management. Microvascular invasion (MVI) is a critical risk factor for postoperative recurrence of hepatocellular carcinoma (HCC). Preknowledge of MVI would assist tailored surgery planning in HCC management. In this multicenter study, we aimed to explore the validity of deep learning (DL) in MVI prediction using two imaging modalities-contrast-enhanced computed tomography (CE-CT) and gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI). A total of 750 HCCs were enrolled from five Chinese tertiary hospitals. Retrospective CE-CT (n = 306, collected between March, 2013 and July, 2019) and EOB-MRI (n = 329, collected between March, 2012 and March, 2019) data were used to train two DL models, respectively. Prospective external validation (n = 115, collected between July, 2015 and February, 2018) was performed to assess the developed models. Furthermore, DL-based attention maps were utilized to visualize high-risk MVI regions. Our findings revealed that the EOB-MRI-based DL model achieved superior prediction outcome to the CE-CT-based DL model (area under receiver operating characteristics curve (AUC): 0.812 vs. 0.736, p = 0.038; sensitivity: 70.4% vs. 57.4%, p = 0.015; specificity: 80.3% vs. 86.9%, p = 0.052). DL attention maps could visualize peritumoral high-risk areas with genuine histopathologic confirmation. Both DL models could stratify high and low-risk groups regarding progression free survival and overall survival (p < 0.05). Thus, DL can be an efficient tool for MVI prediction, and EOB-MRI was proven to be the modality with advantage for MVI assessment than CE-CT.

资助项目Ministry of Science and Technology of China[2017YFA0205200] ; National Natural Science Foundation of China[82001917] ; National Natural Science Foundation of China[81930053] ; National Natural Science Foundation of China[81227901] ; National Natural Science Foundation of China[81527805] ; Chinese Academy of Sciences[GJJSTD20170004] ; Chinese Academy of Sciences[QYZDJ-SSW-JSC005] ; Beijing Municipal Science and Technology Commission[Z161100002616022] ; Beijing Municipal Science and Technology Commission[Z171100000117023]
WOS关键词PREOPERATIVE PREDICTION ; RECURRENCE ; RESECTION ; NOMOGRAM ; RISK
WOS研究方向Oncology
语种英语
出版者MDPI
WOS记录号WOS:000654719300001
资助机构Ministry of Science and Technology of China ; National Natural Science Foundation of China ; Chinese Academy of Sciences ; Beijing Municipal Science and Technology Commission
内容类型期刊论文
源URL[http://ir.ia.ac.cn/handle/173211/44648]  
专题自动化研究所_中国科学院分子影像重点实验室
通讯作者Li, Hongjun; Tian, Jie
作者单位1.SenseBrain Res, Santa Clara, CA 95131 USA
2.Henan Prov Peoples Hosp, Dept Med Imaging, Zhengzhou 450003, Peoples R China
3.Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China
4.Xidian Univ, Sch Life Sci & Technol, Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Xian 710126, Peoples R China
5.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Med, Beijing 100191, Peoples R China
6.Beihang Univ, Sch Bioengn, Beijing 100191, Peoples R China
7.Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
8.Capital Med Univ, Beijing Youan Hosp, Dept Pathol, Beijing 100069, Peoples R China
9.Capital Med Univ, Beijing Youan Hosp, Dept Radiol, Beijing 100069, Peoples R China
10.China Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Shenyang 110000, Peoples R China
推荐引用方式
GB/T 7714
Wei, Jingwei,Jiang, Hanyu,Zeng, Mengsu,et al. Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study[J]. CANCERS,2021,13(10):19.
APA Wei, Jingwei.,Jiang, Hanyu.,Zeng, Mengsu.,Wang, Meiyun.,Niu, Meng.,...&Tian, Jie.(2021).Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study.CANCERS,13(10),19.
MLA Wei, Jingwei,et al."Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study".CANCERS 13.10(2021):19.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace